KalVista changes fiscal year-end from April 30 to December 31

KalVista Pharmaceuticals, Inc.

Board approved change effective March 13, 2025; new fiscal year begins January 1, 2026.
Transition report on Form 10-KT will cover eight-month period May 1 through Dec 31, 2025.
During transition, a 10-Q for quarter ending July 31, 2025 will be filed, then quarters shift to Sept 30, 2025.

item 5.03

KalVista Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-055602

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.